fshd dux4-induced mouse model for studying facioscapulohumeral muscular dystrophy pathology
Published 5 years ago • 697 plays • Length 11:08Download video MP4
Download video MP3
Similar videos
-
1:03:14
what's new in fshd
-
33:26
facioscapulohumeral muscular dystrophy with perkin elmer genomics
-
1:02:25
addressing the gaps in clinical trial readiness for fshd
-
49:50
move study for fsh muscular dystrophy
-
4:55:33
2023 fshd patient day
-
1:36:17
advances in fshd treatments
-
20:27
evaluating regulation of gene expression to treat the root cause of fshd
-
1:03:13
solve fshd, treatment accelerator
-
2:00
new therapeutic technology provides hope for first-ever approved treatment for fshd
-
1:20
the typical diagnostic journey for fshd patients
-
5:11
fshd genetics
-
30:36
updates in facioscapulohumeral muscular dystrophy (fshd)
-
56:47
research update - fshd patient-reported outcomes
-
17:00
2016 fshd patient connect: getting ready for clinical trials
-
8:29
losmapimod as a potential treatment for facioscapulohumeral muscular dystrophy (fshd)
-
1:59
phase ii study testing losmapimod for facioscapulohumeral muscular dystrophy
-
1:00:34
fshd society's 2019 4th quarter ceo report
-
30:16
increasing patient engagement in the fshd muscular dystrophy clinical trial research network
-
1:08
clinical trials and you